About Asymptote
Asymptote is a Healthcare company based in Cambridge (United Kingdom) founded in 1989, and was acquired by GE Healthcare in April 2017. Cryopreservation products for biological samples are developed without liquid nitrogen. Its chief executive, as recorded, is John Morris. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified. Its legal entity is ASYMPTOTE LIMITED.
Company details
Asymptote was founded in 1989 in Cambridge, United Kingdom, within the biotechnology sector. Controlled-rate freezing and thawing systems for live biological samples are provided, with emphasis on liquid nitrogen-free options compatible with clean-room environments. Cryogenic chain technology is employed across operations. The product lineup consists of VIA Freeze research, VIA Freeze duo, and VIA Freeze quad freezers, alongside the VIA thaw automated system, supporting research and storage needs.
- Headquarters Cambridge, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website asymptote.co.uk
- Social LinkedIn
- Acquired by GE Healthcare (Apr 2017)
- Legal Name Asymptote Limited
- Date of Incorporation 22 Sep, 1989
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
- Latest Funding Round$54.02K (USD), Grant
Jan 2018
- InvestorsGE Healthcare
& 1 more
- Acquired byGE Healthcare
(Apr 2017)
Funding Insights of Asymptote
- Total Rounds 1
- Last Round Grant β $54,021
- First Round $54,021
(Jan 2018)
- Investors Count 1
All 1 funding rounds of Asymptote with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $54,021 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in Asymptote
Asymptote has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include GE Healthcare and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Materials management solutions are provided for healthcare organizations. | 1892 | gehealthcare.com | Chicago, United States |
Investor details for Asymptote
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Asymptote
1 people are tracked at Asymptote (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Morris | CEO | Leadership |
Complete people profiles for Asymptote
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Asymptote
3 dated milestones of Asymptote across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Asymptote is founded.
- Exit Acquired by GE Healthcare.
- Funding First funding round of $54K.
Web traffic of Asymptote
Websites that share an audience with Asymptote (asymptote.co.uk).
Websites whose visitors overlap most with Asymptote. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nalgenunc.com | nalgenunc.com | 100% | β | ||
| biogenics.com | 100% | View details | |||
| cryologic.com | 100% | #9,905,193 | View details | ||
| freezerpro.com | 100% | View details | |||
shivaniscientific.com | shivaniscientific.com | 100% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for Asymptote
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Asymptote (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Asymptote
Asymptote was founded in 1989 and raised its 1st funding round 29 years after it was founded.
Asymptote is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
John Morris is the CEO of Asymptote, as recorded in our data.
Asymptote was founded in 1989 in Cambridge, United Kingdom, within the biotechnology sector. Controlled-rate freezing and thawing systems for live biological samples are provided, with emphasis on liquid nitrogen-free options compatible with clean-room environments. Cryogenic chain technology is employed across operations. The product lineup consists of VIA Freeze research, VIA Freeze duo, and VIA Freeze quad freezers, alongside the VIA thaw automated system, supporting research and storage needs.
Asymptote has 2 investors. Key investors include GE Healthcare, and European Union.
Asymptote operates through Asymptote Limited.
Yes. Asymptote was acquired by GE Healthcare in April 2017.
